(Q42255158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ben Thompson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

8

Andrew J Pollard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3

Emma Plested

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Philip C S de Whalley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Elizabeth Nuthall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Omar Omar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ray Borrow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

13 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

Archives of Disease in Childhood

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

686-691

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of meningococcal disease.

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vacc

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Meningococcal carriage by age: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Reconsideration of the use of meningococcal polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2013-303893

10.1136/ARCHDISCHILD-2013-303893

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853000%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference